Kadia TM, Ravandi F, Molica M, Bataller A, et al. Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. Am J Hematol 2023 Aug 27. doi: 10.1002/ajh.27054.
PMID: 37635400